TAIPEI (The China Post) — The Central Epidemic Command Center (CECC, 中央流行疫情指揮中心) said on Wednesday that a total of 18,657 AstraZeneca (AZ) vaccine doses have been administered as of Tuesday.
A follow-up evaluation report by the Food and Drug Administration (FDA, 食藥署), however, shows another person with a severe allergic reaction after receiving the vaccine, the second case since Taiwan started administrating the vaccines.
CECC spokesperson Chuang Jen-hsiang (莊人祥) pointed out that the U.K. and the European Union have both been trying to determine the connection between adverse reactions to the AZ vaccine and cerebral venous sinus thrombosis.
As cerebral venous sinus thrombosis is a rare disease, the CECC indicated that westerners are 10 times more likely to affected than Asian people.
As of press time, the U.K. has administered more than 18 million doses of the vaccine and authorities have reported only 22 cases with adverse reactions.
Chuang added that the main adverse reactions include allergic and feverish symptoms, but announced that all people experiencing such condition have since been discharged from the hospital.